A biodegradable perivascular wrap for controlled, local and directed drug delivery

Journal of Controlled Release

Volumn 161, Issue 1, 2012, Pages 81-89

  Sanders, William G ^a   Hogrebe, Paul C ^b   Grainger, David W ^a,b   Cheung, Alfred K ^a,c   Terry, Christi M ^c  

^a UNIVERSITY OF UTAH   (United States)

^b University of Utah   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Arteriovenous graft; Drug delivery; Hyperplasia; Inflammation; Perivascular wrap; Sunitinib

Indexed keywords

ARTERIOVENOUS GRAFT; HYPERPLASIA; INFLAMMATION; PERIVASCULAR WRAP; SUNITINIB;

AMINO ACIDS; BIODEGRADATION; DIALYSIS; DRUG DELIVERY; GRAFTS; HEMODIALYZERS; HYDROGELS; POLYMERS; TENSILE TESTING; TISSUE;

POLYCAPROLACTONE;

MOLECULAR LAYER; POLYCAPROLACTONE; POLYGLACTIN; POLYMER; SUNITINIB;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY GRAFT; ARTICLE; BIODEGRADABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DIFFUSION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; EXPERIMENTAL PIG; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRATION; HYDROGEL; IN VITRO STUDY; IN VIVO STUDY; MASS SPECTROMETRY; NONHUMAN; PERIVASCULAR POLYMER WRAP; POROSITY; PRIORITY JOURNAL; TENSILE STRENGTH; TISSUE DISTRIBUTION; VEIN GRAFT;

ANIMALS; BLOOD VESSEL PROSTHESIS; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; ELASTIC MODULUS; EQUIPMENT DESIGN; HYALURONIC ACID; INDOLES; JUGULAR VEINS; LACTIC ACID; POLYESTERS; POLYGLYCOLIC ACID; POROSITY; PYRROLES; RECEPTOR PROTEIN-TYROSINE KINASES; SWINE;

EID: 84862619471     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2012.04.029     Document Type: Article

References (55)

1. United States Renal Data System: 2002 Annual Data Report, National Institutes of Health, National Institute of Diabetes and Digestive Diseases, Bethesda, 2002.
2. A.K. Cheung, C. Terry, L. Li, Pathogenesis and local drug delivery for prevention of vascular access stenosis, J. Ren. Nutr. 18 (2008) 140-145. (Pubitemid 350251843)
3. S.J. Ram, J. Work, G.C. Caldito, J.M. Eason, A. Pervez, W.D. Paulson, A randomized controlled trial of blood flow and stenosis surveillance of hemodialysis grafts, Kidney Int. 64 (2003) 272-280. (Pubitemid 36714181)
4. M. Allon, Stent graft or balloon angioplasty alone for dialysis-access grafts, N. Engl. J. Med. 362 (2010) 1939.
5. Z.J. Haskal, S. Trerotola, B. Dolmatch, E. Schuman, S. Altman, S. Mietling, S. Berman, G. McLennan, C. Trimmer, J. Ross, T. Vesely, Stent graft versus balloon angioplasty for failing dialysis-access grafts, N. Engl. J. Med. 362 (2010) 494-503.
6. B.S. Dixon, G.J. Beck,M.A. Vazquez, A. Greenberg, J.A. Delmez, M. Allon, L.M. Dember, J. Himmelfarb, J.J. Gassman, T. Greene, M.K. Radeva, I.J. Davidson, T.A. Ikizler, G.L. Braden, A.Z. Fenves, J.S. Kaufman, J.R. Cotton Jr., K.J. Martin, J.W. McNeil, A. Rahman, J.H. Lawson, J.F. Whiting, B. Hu, C.M. Meyers, J.W. Kusek, H.I. Feldman, Effect of dipyridamole plus aspirin on hemodialysis graft patency, N. Engl. J. Med. 360 (2009) 2191-2201.
7. L. Li, C.M. Terry, D.K. Blumenthal, T. Kuji, T. Masaki, B.C. Kwan, I. Zhuplatov, J.K. Leypoldt, A.K. Cheung, Cellular and morphological changes during neointimal hyperplasia development in a porcine arteriovenous graft model, Nephrol. Dial. Transplant. 22 (2007) 3139-3146. (Pubitemid 350202566)
8. T. Masaki, R. Rathi, G. Zentner, J.K. Leypoldt, S.F. Mohammad, G.L. Burns, L. Li, S. Zhuplatov, T. Chirananthavat, S.J. Kim, S. Kern, J. Holman, S.W. Kim, A.K. Cheung, Inhibition of neointimal hyperplasia in vascular grafts by sustained perivascular delivery of paclitaxel, Kidney Int. 66 (2004) 2061-2069.
9. S.C. Owen, H. Li, W.G. Sanders, A.K. Cheung, C.M. Terry, Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft, J. Control. Release 146 (2010) 23-30.
10. E.R. Edelman, D.H. Adams, M.J. Karnovsky, Effect of controlled adventitial heparin delivery on smooth muscle cell proliferation following endothelial injury, Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 3773-3777.
11. M. Melhem, B. Kelly, J. Zhang, G. Kasting, J. Li, H. Davis, S. Heffelfinger, P. Desai, P. Roy-Chaudhury, Development of a local perivascular paclitaxel delivery system for hemodialysis vascular access dysfunction: polymer preparation and in vitro activity, Blood Purif. 24 (2006) 289-298. (Pubitemid 43800667)
12. B. Kelly, M. Melhem, J. Zhang, G. Kasting, J. Li, M. Krishnamoorthy, S. Heffelfinger, S. Rudich, P. Desai, P. Roy-Chaudhury, Perivascular paclitaxelwraps block arteriovenous graft stenosis in a pig model, Nephrol. Dial. Transplant. 21 (2006) 2425-2431. (Pubitemid 44644513)
13. P.E. Signore, L.S. Machan, J.K. Jackson, H. Burt, P. Bromley, J.E.Wilson, B.M.McManus, Complete inhibition of intimal hyperplasia by perivascular delivery of paclitaxel in balloon-injured rat carotid arteries, J. Vasc. Interv. Radiol. 12 (2001) 79-88. (Pubitemid 32095680)
14. T.R. Kohler, P.M. Toleikis,D.M.Gravett, R.L. Avelar, Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh, J. Vasc. Surg. 45 (2007) 1029-1037 (discussion 1037-1028).
15. W.D. Paulson, N. Kipshidze, K. Kipiani, N. Beridze, M.V. Devita, S. Shenoy, S.S. Iyer, Safety and efficacy of local periadventitial delivery of sirolimus for improving hemodialysis graft patency: first human experience with a sirolimus-eluting collagen membrane (Coll-R), Nephrol. Dial. Transplant. 27 (3) (2012) 1219-1224.
16. S.H. Swedberg, B.G. Brown, R. Sigley, T.N. Wight, D. Gordon, S.C. Nicholls, Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment, Circulation 80 (1989) 1726-1736. (Pubitemid 20031704)
17. A. Jawien, D.F. Bowen-Pope, V. Lindner, S.M. Schwartz, A.W. Clowes, Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty, J. Clin. Invest. 89 (1992) 507-511.
18. M.W. Majesky, M.A. Reidy, D.F. Bowen-Pope, C.E. Hart, J.N. Wilcox, S.M. Schwartz, PDGF ligand and receptor gene expression during repair of arterial injury, J. Cell Biol. 111 (1990) 2149-2158.
19. M.F. Weiss, V. Scivittaro, J.M. Anderson, Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access, Am. J. Kidney Dis. 37 (2001) 970-980. (Pubitemid 32436569)
20. G.A. Ferns, E.W. Raines, K.H. Sprugel, A.S. Motani, M.A. Reidy, R. Ross, Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF, Science 253 (1991) 1129-1132. (Pubitemid 21917260)
21. Y.Makiyama, K. Toba, K. Kato, S. Hirono, T. Ozawa, T. Saigawa, S. Minagawa, M. Isoda, F. Asami, N. Ikarashi, M. Oda, M. Moriyama, M. Higashimura, T. Kitajima, K. Otaki, Y. Aizawa, Imatinibmesilate inhibits neointimal hyperplasia via growth inhibition of vascular smooth muscle cells in a rat model of balloon injury, Tohoku J. Exp. Med. 215 (2008) 299-306.
22. J.E. Vamvakopoulos, L. Petrov, S. Aavik, S. Lehti, E. Aavik, P. Hayry, Synergistic suppression of rat neointimal hyperplasia by rapamycin and imatinib mesylate: implications for the prevention of accelerated arteriosclerosis, J. Vasc. Res. 43 (2006) 184-192. (Pubitemid 43248000)
23. T.T. Huynh, M.G. Davies, L. Barber, E. Svendsen, P.O. Hagen, Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts, J. Surg. Res. 77 (1998) 104-111. (Pubitemid 28413499)
24. S. Faivre, G. Demetri,W. Sargent, E. Raymond, Molecular basis for sunitinib efficacy and future clinical development, Nat. Rev. Drug Discov. 6 (2007) 734-745. (Pubitemid 47338181)
25. S. Bhardwaj, H. Roy, T. Heikura, S. Yla-Herttuala, VEGF-A, VEGF-D and VEGFD(DeltaNDeltaC) induced intimal hyperplasia in carotid arteries, Eur. J. Clin. Invest. 35 (2005) 669-676. (Pubitemid 41640902)
26. T.A. Dechert, A.E. Ducale, S.I. Ward, D.R. Yager, Hyaluronan in human acute and chronic dermal wounds, Wound Repair Regen. 14 (2006) 252-258. (Pubitemid 43979254)
27. C.M. Terry, S.E. Kim, L. Li, K.C. Goodrich, J.R. Hadley, D.K. Blumenthal, D.L. Parker, A.K. Cheung, Longitudinal assessment of hyperplasia using magnetic resonance imaging without contrast in a porcine arteriovenous graft model, Acad. Radiol. 16 (2009) 96-107.
28. S. Baratte, S. Sarati, E. Frigerio, C.A. James, C. Ye, Q. Zhang, Quantitation of SU1 1248, an oral multi-target tyrosine kinase inhibitor, and its metabolite in monkey tissues by liquid chromatograph with tandem mass spectrometry following semiautomated liquid-liquid extraction, J. Chromatogr. A 1024 (2004) 87-94. (Pubitemid 37532538)
29. P. Minkin, M. Zhao, Z. Chen, J. Ouwerkerk, H. Gelderblom, S.D. Baker, Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry, J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 874 (2008) 84-88.
30. Q. Zhou, J.M. Gallo, Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography-electrospray ionization-tandem mass spectrometry and pharmacokinetic application, J. Pharm. Biomed. Anal. 51 (2010) 958-964.
31. S. Duvvuri, K. Gaurav Janoria, A.K. Mitra, Effect of polymer blending on the release of ganciclovir from PLGA microspheres, Pharm. Res. 23 (2006) 215-223. (Pubitemid 43214678)
32. J.A. Burdick, G.D. Prestwich, Hyaluronic acid hydrogels for biomedical applications, Adv. Mater. 23 (2011) H41-H56.
33. G.D. Prestwich, J.W. Kuo, Chemically-modified HA for therapy and regenerative medicine, Curr. Pharm. Biotechnol. 9 (2008) 242-245.
34. Y. Liu, X. Zheng Shu, G.D. Prestwich, Biocompatibility and stability of disulfide-crosslinked hyaluronan films, Biomaterials 26 (2005) 4737-4746. (Pubitemid 40343022)
35. E. Pektok, B. Nottelet, J.C. Tille, R. Gurny, A. Kalangos, M. Moeller, B.H. Walpoth, Degradation and healing characteristics of small-diameter poly(epsilon-caprolactone) vascular grafts in the rat systemic arterial circulation, Circulation 118 (2008) 2563-2570.
36. C.G. Pitt, M.M. Gratzl, G.L. Kimmel, J. Surles, A. Schindler, Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone) , and their copolymers in vivo, Biomaterials 2 (1981) 215-220. (Pubitemid 12195194)
37. R.A. Miller, J.M. Brady, D.E. Cutright, Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios, J. Biomed. Mater. Res. 11 (1977) 711-719. (Pubitemid 8159588)
38. M.E. Russell, Comprehensive review of the polymer-based taxol release kinetics and animal data: insights into efficacy and toxicity, 2002 Drug-Eluting Stent Summit, 2002.
39. X. Liu, L. Lei, J.W. Hou, M.F. Tang, S.R. Guo, Z.M.Wang, K.M. Chen, Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxeleluting stent application, J. Mater. Sci. Mater. Med. 22 (2011) 327-337.
40. L. Lei, X. Liu, S. Guo, M. Tang, L. Cheng, L. Tian, 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: drug release, microstructure, and ex vivo permeation behaviors, J. Control. Release 146 (2010) 45-53.
41. B. Nottelet, E. Pektok, D.Mandracchia, J.C. Tille, B.Walpoth, R. Gurny, M.Moller, Factorial design optimization and in vivo feasibility of poly(epsilon-caprolactone)- micro- and nanofiber-based small diameter vascular grafts, J. Biomed. Mater. Res. A 89 (2009) 865-875.
42. L. Lu, S.J. Peter, M.D. Lyman, H.L. Lai, S.M. Leite, J.A. Tamada, S. Uyama, J.P. Vacanti, R. Langer, A.G. Mikos, In vitro and in vivo degradation of porous poly(DL-lactic-coglycolic acid) foams, Biomaterials 21 (2000) 1837-1845. (Pubitemid 30398502)
43. J.K. Jackson, J. Smith, K. Letchford, K.A. Babiuk, L. Machan, P. Signore, W.L. Hunter, K. Wang, H.M. Burt, Characterization of perivascular poly(lactic-co-glycolic acid) films containing paclitaxel, Int. J. Pharm. 283 (2004) 97-109. (Pubitemid 39200931)
44. D.D. Hile, M.L. Amirpour, A. Akgerman, M.V. Pishko, Active growth factor delivery frompoly(D, L-lactide-co-glycolide) foams prepared in supercritical CO(2), J. Control. Release 66 (2000) 177-185. (Pubitemid 30160855)
45. W.F. Cheung, T.F. Cruz, E.A. Turley, Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors, Biochem. Soc. Trans. 27 (1999) 135-142. (Pubitemid 29086023)
46. G. Tufveson, B. Gerdin, E. Larsson, T. Laurent, J. Wallander, A. Wells, R. Hallgren, Hyaluronic acid accumulation; the mechanism behind graft rejection edema, Transpl. Int. 5 (Suppl. 1) (1992) S688-S689.
47. X. Zheng Shu, Y. Liu, F.S. Palumbo, Y. Luo, G.D. Prestwich, In situ crosslinkable hyaluronan hydrogels for tissue engineering, Biomaterials 25 (2004) 1339-1348. (Pubitemid 37476210)
48. M.P. Lutolf, J.A. Hubbell, Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition, Biomacromolecules 4 (2003) 713-722. (Pubitemid 36701243)
49. D.L. Elbert, A.B. Pratt, M.P. Lutolf, S. Halstenberg, J.A. Hubbell, Protein delivery from materials formed by self-selective conjugate addition reactions, J. Control. Release 76 (2001) 11-25. (Pubitemid 32786881)
50. A.C. Grayson, G. Voskerician, A. Lynn, J.M. Anderson, M.J. Cima, R. Langer, Differential degradation rates in vivo and in vitro of biocompatible poly(lactic acid) and poly(glycolic acid) homo- and co-polymers for a polymeric drug-delivery microchip, J. Biomater. Sci. Polym. Ed. 15 (2004) 1281-1304. (Pubitemid 39419596)
51. A. Santovena, C. Alvarez-Lorenzo, A. Concheiro, M. Llabres, J.B. Farina, Structural properties of biodegradable polyesters and rheological behaviour of their dispersions and films, J. Biomater. Sci. Polym. Ed. 16 (2005) 629-641. (Pubitemid 41348795)
52. M. Miyajima, A. Koshika, J. Okada, M. Ikeda, Mechanism of drug release from poly(L-lactic acid) matrix containing acidic or neutral drugs, J. Control. Release 60 (1999) 199-209. (Pubitemid 29335946)
53. R.A. Giordano, B.M. Wu, S.W. Borland, L.G. Cima, E.M. Sachs, M.J. Cima, Mechanical properties of dense polylactic acid structures fabricated by three dimensional printing, J. Biomater. Sci. Polym. Ed. 8 (1996) 63-75. (Pubitemid 26377597)
54. J. Manson, D. Dixon, The Influence of Solvent Processing on Polyester Bioabsorbable Polymers, J. Biomater. Appl. 26 (5) (2012) 623-634.
55. M.S. El-Kurdi, Y. Hong, J.J. Stankus, L. Soletti, W.R. Wagner, D.A. Vorp, Transient elastic support for vein grafts using a constricting microfibrillar polymer wrap, Biomaterials 29 (2008) 3213-3220.